These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37464305)

  • 1. Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran.
    Saki N; Babaahmadi-Rezaei H; Rahimi Z; Raeisizadeh M; Jorfi F; Seif F; Cheraghian B; Ghaderi-Zefrehi H; Rezaei M
    BMC Cardiovasc Disord; 2023 Jul; 23(1):358. PubMed ID: 37464305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
    Al-Shamsi S; Regmi D; Govender RD
    BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study.
    Dehghan A; Jahangiry L; Khezri R; Jafari A; Pezeshki B; Rezaei F; Aune D
    BMC Endocr Disord; 2024 Jun; 24(1):95. PubMed ID: 38915041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of cardiovascular diseases and associated factors among adults from southwest Iran: Baseline data from Hoveyzeh Cohort Study.
    Saki N; Karandish M; Cheraghian B; Heybar H; Hashemi SJ; Azhdari M
    BMC Cardiovasc Disord; 2022 Jul; 22(1):309. PubMed ID: 35804295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Boehringer Ingelheim employee study (Part 2): 10-year cardiovascular diseases risk estimation.
    Kempf K; Martin S; Döhring C; Dugi K; Haastert B; Schneider M
    Occup Med (Lond); 2016 Oct; 66(7):543-550. PubMed ID: 27387917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study.
    Dehghan A; Ahmadnia Motlagh S; Khezri R; Rezaei F; Aune D
    J Transl Med; 2023 Oct; 21(1):687. PubMed ID: 37789412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study.
    Chia YC; Gray SY; Ching SM; Lim HM; Chinna K
    BMJ Open; 2015 May; 5(5):e007324. PubMed ID: 25991451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a cost-effective CVD prediction model using lifestyle factors. A cohort study in Pakistan.
    Naheeda P; Sharifullah K; Ullah SS; Azeem AM; Shahzad Y; Kinza W
    Afr Health Sci; 2020 Jun; 20(2):849-859. PubMed ID: 33163052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
    Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
    Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of cardiovascular disease risk factors and the Framingham Risk Score in patients undergoing percutaneous intervention over the last 17 years by gender: time-trend analysis from the Mayo Clinic PCI Registry.
    Lee MS; Flammer AJ; Kim HS; Hong JY; Li J; Lennon RJ; Lerman A
    J Prev Med Public Health; 2014 Jul; 47(4):216-29. PubMed ID: 25139168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Cardiovascular Risk and Perceived Fatigability in Mid-to-Late Life.
    Qiao Y; Martinez-Amezcua P; Wanigatunga AA; Urbanek JK; Simonsick EM; Ferrucci L; Schrack JA
    J Am Heart Assoc; 2019 Aug; 8(16):e013049. PubMed ID: 31409206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis of the cardiovascular disease risk factor profiles of Pacific peoples and Europeans living in New Zealand assessed in routine primary care: PREDICT CVD-11.
    Grey C; Wells S; Riddell T; Kerr A; Gentles D; Pylypchuk R; Marshall R; Ameratunga S; Drury P; Elley CR; Kyle C; Exeter D; Jackson R
    N Z Med J; 2010 Feb; 123(1309):62-75. PubMed ID: 20186243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of gender and place of residence on cardiovascular diseases and their risk factors. The Isfahan cohort study.
    Sarrafzadegan N; Talaei M; Kelishadi R; Toghianifar N; Sadeghi M; Oveisgharan S; Kabiri P; Tavassoli A; Mohammadifard N; Thomas GN; Marshall T
    Saudi Med J; 2012 May; 33(5):533-40. PubMed ID: 22588815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease risk factors in patients with confirmed cardiovascular disease.
    Aghaeishahsavari M; Noroozianavval M; Veisi P; Parizad R; Samadikhah J
    Saudi Med J; 2006 Sep; 27(9):1358-61. PubMed ID: 16951773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants.
    Alaa AM; Bolton T; Di Angelantonio E; Rudd JHF; van der Schaar M
    PLoS One; 2019; 14(5):e0213653. PubMed ID: 31091238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal body fat percentage cut-off values for identifying cardiovascular risk factors in Mongolian and Han adults: a population-based cross-sectional study in Inner Mongolia, China.
    Li Y; Wang H; Wang K; Wang W; Dong F; Qian Y; Gong H; Xu G; Li G; Pan L; Zhu G; Shan G
    BMJ Open; 2017 Apr; 7(4):e014675. PubMed ID: 28420663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep duration and Framingham´s cardiovascular risk score: results from the Hoveyzeh Cohort Study (HCS).
    Cheraghian B; Heybar H; Saki N; Raeisizadeh M; Hashemi SJ; Bitaraf S
    BMC Cardiovasc Disord; 2023 Nov; 23(1):570. PubMed ID: 37986150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.